Cinven sells remaining Spire stake

The full exit follows the sale of a 29.9% stake in Spire to Remgro on 22 June and of 8.4% on 26 June.

Spire was listed in a July 2014 IPO that valued the company at £1.1bn. Since listing at 210p per share, the company has seen share price growth in excess of 50%, peaking at 390p in March. Trading closed on Wednesday 13 July at 349p.

Company
Spire is a British network of private hospitals headquartered in London, with 39 hospitals and 14 clinics across the UK.

The group had revenues of £856m in 2014 and employs 6,900 people.

People
Supraj Rajagopalan is a partner at Cinven. Rob Roger is the CEO of Spire.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• UK / Ireland
• Healthcare
• Exits
• Cinven